Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 1,273-1,284 of 10,612

Behavioral study icon

RecruitingNCT06482567

Promoting Improved Functioning Among People Experiencing Stressful Situations

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 50 Years

Countries: United States
Sponsor: University of North Carolina, Chapel Hill
Condition: PTSD

Behavioral study icon

RecruitingNCT06038318

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyBehavioralFrom 12 Years to 25 Years

Countries: United States
Sponsor: Dana-Farber Cancer Institute
Condition: Anxiety

Device study icon

RecruitingNCT06400810

Proximal Risk for Suicide in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityDeviceFrom 13 Years to 17 Years

Countries: United States
Sponsor: Oregon Health and Science University
Condition: Suicidality

Drug study icon

RecruitingNCT06989957

Psilocybin and Methylenedioxymethamphetamine (MDMA) for PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugOver 21 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: PTSD

Drug study icon

RecruitingNCT06796062

Psilocybin for Addiction (OUD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: Addiction

Drug study icon

RecruitingNCT04123314

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 85 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression

Drug study icon

RecruitingNCT06899594

Psilocybin for Methamphetamine Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 25 Years to 65 Years

Countries: United States
Sponsor: Kevin Murnane
Condition: Addiction

Drug study icon

RecruitingNCT06355414

Psilocybin in Chronic Low Back Pain and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 21 Years to 80 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression

Drug study icon

RecruitingNCT07226232

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Depression

Drug study icon

RecruitingNCT06810310

Psilocybin on Brain Mechanisms of Motivation in OUD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

RecruitingNCT06405607

Psilocybin or Ketamine for Addiction: An Active Comparator study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: University of Iowa
Condition: Addiction

Drug study icon

RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 22 Years to 65 Years

Countries: United States
Sponsor: University of Texas at Austin
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.